Urinary Tract Infection Panel
Promus Diagnostics’ comprehensive molecular UTI panel provides a complete set of data much faster than traditional urine culture — making results more relevant, meaningful and reliable.
How other labs test for UTIs
brings the next evolution in UTI testing
The Promus Pathway is the next level of PCR reporting. Promus Pathway identifies and reports 30+ of the most relevant UTI pathogens and 20+ antibiotic resistant genes in the established CFU/ml reporting methodology. Promus Pathway’s CFU/ml reporting delivers faster, more comprehensive, and accurate treatment guidance (drug, dosage and duration) compared to C&S or standard PCR options. Unlike C&S which is only 57% accurate and takes as much as 72 hours, Promus Pathway produces test results in just 24 hours with 95%+ accuracy, eliminating the need to treat patients empirically and insuring the best possible antibiotic stewardship.
Promus is the only PCR lab to identify, isolate and design methods to proliferate over 100 live pathogens across multiple infectious disease assays and create a validated reporting algorithm that couples highly accurate results in CFUs/mL and all related antibiotic resistance genes. Promus is able to provide the only fully validated antibiotic treatment guidance that is easily translated into standard antibiotic dosing protocols for each pathogen and the associated antibiotic resistance genes.
Urinary Tract Infection
+ Antibiotic Resistance Genes (UTI+ABR)
Promus Diagnostics Molecular PCR UTI Test is the Solution
Urinary Tract Infections (UTI) are the most common bacterial infection among long term care residents and the second most common infection diagnosed in the acute hospital setting. UTIs account for almost 5% of all emergency department visits by adults aged 65 years and older in the United States each year.
Traditional testing for a UTI involves a urine culture which can take days to complete, greatly reducing sensitivity and accuracy. Without an accurate identification of the pathogen, healthcare providers may treat the patient with a course of antibiotics that may not be the optimal choice based on pathogens present resulting in persistent or recurring UTIs.
A recent study by Washington University found that of the 670,450 women tested, 46.7% “received antibiotic prescriptions for inappropriate agents” and 76.1% received antibiotics for an incorrect duration.1
At Promus Diagnostics we provide a better solution for identifying the pathogens causing an UTI using real-time PCR technology. Our UTI+ABR test panel can quickly and accurately identify 31 different infection causing pathogens and 22 antimicrobial resistance markers, giving healthcare providers the clearest and most robust information to develop a treatment regimen.
Identification where culture or dipstick may not have detected infection, or inconclusive due to sample contamination
Reduce or eliminate recurrent infections based on superior identification of Uropathogens for proper treatment
Informed drug selection to remediate infection, decrease incidents of adverse events as well as lessen the potential for antibiotic resistance
“Antibiotic stewardship is the effort to measure and improve how antibiotics are prescribed by clinicians and used by patients.”2